Minimum Appropriate Follow-Up Reduces Mortality After Endoprosthesis Implantation

No study has been able to prove long-term benefit of regular imaging follow-up after abdominal aortic aneurysm repair by means of endoprosthesis implantation. This is important because the costs for these studies are high, which should be added to potential radiation and contrast morbidity.

Un seguimiento mínimo y apropiado reduce la mortalidad luego de una endoprótesis

This work sought to characterize the association between post-endovascular abdominal aortic aneurysm repair imaging frequency and long-term survival.

 

Minimum appropriate imaging follow-up was defined as a computerized tomography (CT) scan or ultrasound of the abdomen within 90 days of the procedure, as well as every 15 months thereafter. A multivariate analysis was conducted to determine the association between compliance with minimum appropriate imaging follow-up over time and all-cause mortality.


Read also: Polymer-Free DES Also Show Efficacy in Anticoagulated Patients with High Risk for Bleeding”.


The study enrolled 4988 patients treated with an endoprosthesis, and the mean follow-up was 3.4 years. Ninety-day mortality was 1.6%. Among those who survived over 90 days, 87% (n = 4251 of 4902) underwent at least one CT scan or ultrasound of the abdomen within 3 months, but only 58% (n = 2859 of 4902) came back afterwards to meet minimum appropriate imaging follow-up criteria.

 

Infrequent imaging correlated with lower follow-up by an interventional cardiologist or the vascular surgeon who performed the implantation, but not with infrequent primary care. Patients continued visiting their primary care physician, who did not refer them to specialists in a timely manner for minimum appropriate follow-up for their abdominal aortic aneurysm.

 

Consistently meeting minimum appropriate follow-up criteria was associated with a lower mortality rate when compared with patients who did not undergo a scan within 90 days (hazard ratio [HR]: 0.82; 95% confidence interval [CI]: 0.69-0.96; p = 0.014), or when compared with patients who underwent a first imaging follow-up within 90 days but missed subsequent follow-up instances (HR: 0.78; 95% CI: 0.68-0.91; p = 0.001).


Read also: Pacemaker Implantation After TAVI Raises Costs But Not the Incidence of Adverse Events”.


The longer the patients remained within the minimum appropriate follow-up protocol, the lower the mortality rates.

 

Conclusion

These data support efforts to improve long term follow-up of patients who receive an endoprosthesis during infrarenal aortic aneurysm repair.

 

Editorial

The lower mortality rates observed with regular follow-up after prosthesis implantation can be partially explained by imaging studies. Imaging follow-up may actually be a subrogated endpoint, and reduced mortality may be a consequence of, for example, better control of cardiovascular risk factors, or a change in lifestyle after the procedure.

 

Patients who disregarded the follow-up still visited their primary care physician regularly, which means that there is an opportunity to improve communication with these physicians in order to obtain adequate imaging follow-up.

 

Original title: The Impact of Compliance with Imaging Follow-up on Mortality After Endovascular Abdominal Aortic Aneurysm Repair: A Population Based Cohort Study.

Reference: C. de Mestral et al. Eur J Vasc Endovasc Surg (2017). Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...